✦ LIBER ✦

The clinical development of MEK inhibitors

✍ Scribed by Zhao, Yujie; Adjei, Alex A.

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

23 Clinical Status of RAF/MEK Inhibitors

✍ Weber, J.; Daud, A.; Infante, J.; Sosman, J.; Flaherty, K.; Kefford, R.; Hamid, 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 56 KB

Clinical experience of MEK inhibitors in

✍ Ding Wang; Scott A. Boerner; James D. Winkler; Patricia M. LoRusso 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 207 KB

From basic research to clinical developm

✍ Christophe Frémin; Sylvain Meloche 📂 Article 📅 2010 🏛 BioMed Central 🌐 English ⚖ 1009 KB

Pre-clinical development of farnesyltran

✍ Robert B. Lobell; Nancy E. Kohl 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 603 KB

373 The oral MEK1/MEK2 inhibitor, GSK112

✍ M.S. Gordon; J.R. Infante; W. Messersmith; L.A. Fecher; N.J. Vogelzang; D. Cox; 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 46 KB

Inhibitors of Raf kinase and MEK signali

✍ Nithya Ramnath; Alex Adjei 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 469 KB